BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TRIM24, O15164, 8805, ENSG00000122779, TIF1ALPHA, TF1A, TIF1A, hTIF1, Tif1a, TIF1, RNF82, PTC6 AND Diagnosis
12 results:

  • 1. Anti-Mi-2 and Anti-tif1-γ Double-Positive Juvenile Dermatomyositis Treated under diagnosis of Chronic Eczema: A Case Report.
    Yoshida S; Matsumoto H; Fujita Y; Yokose K; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Yaguchi T; Aita T; Kusano M; Yamamoto T; Watanabe H; Migita K
    Tohoku J Exp Med; 2022 Apr; 256(4):303-308. PubMed ID: 35296571
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis.
    Marzęcka M; Niemczyk A; Rudnicka L
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):289-296. PubMed ID: 35147864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody.
    Zhao Q; Chen Y; Diao L; Zhang S; Wu D; Xue F; Xia Q; Li H; Zheng J; Cao H
    Rheumatology (Oxford); 2022 May; 61(5):2176-2184. PubMed ID: 34508564
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast cancer.
    Piras M; Panebianco M; Garibaldi M; Roberto M; Merlonghi G; Pellegrini P; Marchetti P
    Curr Oncol; 2021 May; 28(3):1957-1961. PubMed ID: 34073827
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Amyopathic and anti-tif1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria.
    Didona D; Juratli HA; Scarsella L; Keber U; Eming R; Hertl M
    Eur J Dermatol; 2020 Jun; 30(3):279-288. PubMed ID: 32666928
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report.
    Osaki M; Tachikawa R; Ohira J; Hara S; Tomii K
    Invest New Drugs; 2021 Feb; 39(1):251-255. PubMed ID: 32651759
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Anti-tif1-γ autoantibodies: warning lights of a tumour autoantigen.
    De Vooght J; Vulsteke JB; De Haes P; Bossuyt X; Lories R; De Langhe E
    Rheumatology (Oxford); 2020 Mar; 59(3):469-477. PubMed ID: 31883334
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis.
    Gono T; Kuwana M
    Expert Rev Clin Immunol; 2020 Jan; 16(1):79-89. PubMed ID: 31779485
    [No Abstract]    [Full Text] [Related]  

  • 11. Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
    Shibata C; Kato J; Toda N; Imai M; Fukumura Y; Arai J; Kurokawa K; Kondo M; Takagi K; Kojima K; Ohki T; Seki M; Yoshida M; Suzuki A; Tagawa K
    J Med Case Rep; 2019 Jun; 13(1):168. PubMed ID: 31153385
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults.
    Dinnes J; Deeks JJ; Chuchu N; Matin RN; Wong KY; Aldridge RB; Durack A; Gulati A; Chan SA; Johnston L; Bayliss SE; Leonardi-Bee J; Takwoingi Y; Davenport C; O'Sullivan C; Tehrani H; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011901. PubMed ID: 30521688
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.